Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
about
Schizophrenia and violence: systematic review and meta-analysisImpact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophreniaImpact of involuntary out-patient commitment on reducing hospital services: 2-year follow-upMedication adherence in schizophreniaGenetics of Common Antipsychotic-Induced Adverse EffectsCosts of treating patients with schizophrenia who have illness-related crisis eventsMedication adherence levels and differential use of mental-health services in the treatment of schizophreniaMaintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trialsTreatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patientsThe cost of relapse and the predictors of relapse in the treatment of schizophreniaInvolvement in the US criminal justice system and cost implications for persons treated for schizophrenia.Changing the landscape of an urban public mental health system: the 2008 New York State/New York City Mental Health-Criminal Justice Review PanelOlanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review.Predictors of switching antipsychotic medications in the treatment of schizophreniaPoor adherence to medications may be associated with falls.Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injectionNonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium.Access to credible information on schizophrenia patients' medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers.Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychoticsTreatment outcomes in schizophrenia: qualitative study of the views of family carersSustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational studyCriminal behavior among persons with schizophrenia in rural China.Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR databaseImpact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand.Patient perspectives on antipsychotic treatments and their association with clinical outcomes.A meta-analysis of the Val158Met COMT polymorphism and violent behavior in schizophrenia.Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nursesMoney for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders.Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalizationThe efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese populationDevelopment of controlled-release matrix tablet of risperidone: influence of Methocel®- and Ethocel®-based novel polymeric blend on in vitro drug release and bioavailabilityThe management of schizophrenia: focus on extended-release quetiapine fumarate.Polypharmacy or medication washout: an old tool revisitedPsychotropic medication nonadherence among United States Latinos: a comprehensive literature review.High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China.Adherence to antipsychotics among Latinos and Asians with schizophrenia and limited English proficiency.A retrospective observational study of the effectiveness of paliperidone palmitate on acute inpatient hospitalization ratesHow patient cost-sharing trends affect adherence and outcomes: a literature review.Tecla: a telephone- and text-message based telemedical concept for patients with severe mental health disorders--study protocol for a controlled, randomized, study.
P2860
Q21092358-14D3059E-DDDC-4D33-9BD5-31CAC4F749BCQ24597701-F796800F-CEA3-447B-A04E-66ED06341A45Q26772275-42DFB6FE-15F1-490D-83DD-1F34FD3BD55CQ26823655-4D5AFFBC-0AEB-41BD-B165-95B6681B33FEQ28072893-53B24D2D-8013-4D61-B0C9-F259199C5852Q33363460-61E96BE1-991A-496D-8C16-8D4A62BE8C70Q33399275-0E7B48B0-0E92-4039-93B0-B172137E57CBQ33425007-76FF9828-6DCF-470C-BA5F-0D7FBE5D132EQ33488323-809D77F5-D59F-4D13-9E7B-97137AFAA055Q33522776-C7EF839F-AFA0-4E10-9FA4-DCC99C9B7823Q33527102-26F5C544-FBC4-46A1-B9B5-AC9945EBDBBAQ33651711-15AB2FC1-2866-473C-BDC6-8A9E2D6A8EB6Q33680103-C966175D-2A97-414F-BD17-6263516DC0A0Q33709704-CD1FB639-A527-43BE-AD83-46294C1EF44FQ33790431-954C8884-50A4-4AD1-8C9A-DA10D8686608Q33817737-7DFAF6CC-024C-4224-9F22-1557502612E5Q33857710-E9FAC974-8F59-46E0-A917-20A2793AC060Q33862078-0C67189F-0A89-42BC-8DC0-E3AB3BC56572Q33879034-1CF64E99-A471-46C3-97DD-70EA758775ABQ33903511-05090A55-63C0-4C2B-A1A4-8DA096EAD4B9Q33922627-F96659BC-3087-4774-A5BE-4380CE48FFC0Q34003858-805D0D69-7489-4ABC-B6C9-46090DE50A0CQ34194668-730C0088-E6B1-4BC1-A221-854CF20EDA8BQ34208127-B6494E97-282D-453F-B2B4-9127276BBAA7Q34231559-209882F3-EAD4-4FAB-AE71-CC50B09B13F2Q34231565-A31807F4-5729-4E86-81E4-D5A094B6D47EQ34385060-74E636E0-F0CE-4F76-BF92-9FC4B8359918Q34588656-C6ACB63E-C7CA-40F7-818C-FC82230804ABQ34650576-9DDBE9A3-43F3-4DD6-882D-22397A8DA049Q35008229-36FEDBEB-E0ED-452F-8552-F8D101F24513Q35021287-CD7F82CA-6A10-4A2B-AFF7-86C49DC26AA1Q35100385-3B0DA492-979D-4E56-979E-3E145F7C0161Q35327044-F887A658-EB84-42A1-B251-4653B06B7CC1Q35548200-511A0B82-6A55-447F-AA5F-51FC8BBAD005Q35569720-03C04115-FAE8-408B-B586-FBAE3279126EQ35605892-CBD4AF6A-00A5-47FD-B119-05ECF3CCCE81Q35606405-135C2760-C4DF-4249-A30B-BCB01ACA8360Q35688404-957839B7-3168-48A0-B1FD-B9EB3CFEC3E5Q35752951-376BBA8A-645A-4360-A3C3-CE2BA244BA16Q35832638-66BD7BB8-27BE-46E6-BD79-CE77D6B2EBFC
P2860
Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Medication adherence and long- ...... f schizophrenia in usual care.
@ast
Medication adherence and long- ...... f schizophrenia in usual care.
@en
Medication adherence and long- ...... f schizophrenia in usual care.
@nl
type
label
Medication adherence and long- ...... f schizophrenia in usual care.
@ast
Medication adherence and long- ...... f schizophrenia in usual care.
@en
Medication adherence and long- ...... f schizophrenia in usual care.
@nl
prefLabel
Medication adherence and long- ...... f schizophrenia in usual care.
@ast
Medication adherence and long- ...... f schizophrenia in usual care.
@en
Medication adherence and long- ...... f schizophrenia in usual care.
@nl
P2093
P1476
Medication adherence and long- ...... f schizophrenia in usual care.
@en
P2093
Baojin Zhu
Douglas E Faries
Frank R Ernst
Jeff W Swanson
Marvin S Swartz
P304
P577
2006-03-01T00:00:00Z